
Besiflox0.6%
Aristopharma Ltd.
Besifloxacin ophthalmic suspension is FDA-approved for the treatment of bacterial conjunctivitis (pink eye) caused by susceptible strains of bacteria in patients 1 year of age and older.
Besifloxacin ophthalmic suspension is FDA-approved for the treatment of bacterial conjunctivitis (pink eye) caused by susceptible strains of bacteria in patients 1 year of age and older.
Besifloxacin is intended for topical ophthalmic (eye) use only and is not approved for any systemic infection, viral conjunctivitis, or fungal/other non-bacterial eye infections.
| Indication | Age Group | Dose |
|---|---|---|
| Bacterial conjunctivitis | Adults and children 1 year of age and older | Instill 1 drop of Besifloxacin in the affected eye(s) 3 times daily, 4 to 12 hours apart, for 7 days |
| Bacterial conjunctivitis | Children under 1 year of age | Safety and efficacy of Besifloxacin have not been established; not recommended |
Antibiotic stewardship: Take Besifloxacin exactly as prescribed by your physician; complete the full 7-day course even if symptoms improve earlier. Do not stop, extend, skip doses, or share this medicine with others without medical advice, as incomplete courses may promote the growth of resistant bacteria.
The most commonly reported adverse reaction with Besifloxacin in clinical trials was:
Other reported adverse reactions, generally mild and localized to the eye, include:
Hypersensitivity reactions (see Contraindications) can occur rarely; discontinue Besifloxacin and seek medical attention if signs of an allergic reaction occur.
Besifloxacin ophthalmic suspension is contraindicated in patients with known hypersensitivity to besifloxacin or to other fluoroquinolone antibacterial agents.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.